Frontiers in Aging Neuroscience,
Journal Year:
2019,
Volume and Issue:
11
Published: Dec. 11, 2019
Post-stroke
systemic
injections
of
insulin-like
growth
factor
1
(IGF-1)
exert
neuroprotective
effects
in
rats.
In
the
current
study,
we
aimed
to
test
efficacy
IGF-1
neuroprotection
aged
rats
(24-25
months
old)
and
compare
results
with
adult
(6-7
old).
Furthermore,
addressed
putative
differences
microglial
responses
Rats
were
subjected
ischemic
stroke
while
they
conscious
by
infusing
endothelin-1
(Et-1)
through
a
guide
cannula
that
was
implemented
vicinity
middle
cerebral
artery
(MCA).
given
subcutaneous
(1
mg/kg)
at
30
min
120
after
insult.
treatment
reduced
infarct
size
34%
38%
rats,
respectively.
The
treated
also
showed
significant
improvement
sensorimotor
function
following
stroke,
this
not
significantly
affected
displayed
exaggerated
activation
microglia
hemisphere.
Significant
reduction
only
detected
specific
regions
ipsilateral
hemisphere
We
show
an
stroke.
It
remains
be
established,
however,
whether
age-related
changes
affect
behavioral
outcome.
Molecular Therapy,
Journal Year:
2020,
Volume and Issue:
29(4), P. 1439 - 1458
Published: Dec. 10, 2020
Contrasting
myelin
damage
through
the
generation
of
new
myelinating
oligodendrocytes
represents
a
promising
approach
to
promote
functional
recovery
after
stroke.
Here,
we
asked
whether
activation
microglia
and
monocyte-derived
macrophages
affects
regenerative
process
sustained
by
G
protein-coupled
receptor
17
(GPR17)-expressing
oligodendrocyte
precursor
cells
(OPCs),
subpopulation
OPCs
specifically
reacting
ischemic
injury.
GPR17-iCreERT2:CAG-eGFP
reporter
mice
were
employed
trace
fate
GPR17-expressing
OPCs,
labeled
green
fluorescent
protein
(GFP),
permanent
middle
cerebral
artery
occlusion.
By
microglia/macrophages
pharmacological
depletion
studies,
show
that
innate
immune
favor
GFP+
OPC
reaction
limit
early
injury,
whereas
they
lose
their
pro-resolving
capacity
acquire
dystrophic
"senescent-like"
phenotype
at
later
stages.
Intracerebral
infusion
microglia-derived
extracellular
vesicles
(EVs)
restores
protective
functions,
limiting
senescence
during
post-stroke
phase,
enhances
maturation
lesion
borders,
resulting
in
ameliorated
neurological
functionality.
In
vitro
experiments
EV-carried
transmembrane
tumor
necrosis
factor
(tmTNF)
mediates
pro-differentiating
effects
on
with
future
implications
for
therapies.
Biological and Pharmaceutical Bulletin,
Journal Year:
2022,
Volume and Issue:
45(9), P. 1269 - 1275
Published: Aug. 31, 2022
Edaravone,
an
antioxidant
protective
agent,
has
anti-cerebral
ischemic
reperfusion
injury
(CIRI)
effects,
but
its
anti-CIRI
mechanism
is
unclear.
The
aim
of
this
study
to
investigate
the
edaravone
based
on
nuclear
factor-E2-related
factor
2
(Nrf2)/ferroportin
(FPN)
pathway
that
regulates
ferroptosis-mediated
cerebral
ischemia-reperfusion
injury.
We
evaluated
brain
by
constructing
a
middle
artery
occlusion
and
(MCAO/R)
model
in
rats.
results
showed
infarct
volume
neurological
impairment
scores
were
increased
rats,
with
impaired
sensorimotor
ability;
furthermore,
tissue
glutathione
(GSH)
content
was
decreased,
Fe2+,
malondialdehyde
(MDA)
lipide
peroxide
(LPO)
increased,
expression
level
peroxidase
4
(GPX4),
key
protein
ferroptosis,
also
decreased.
Meanwhile,
Nrf2
FPN
decreased
after
ischemia-reperfusion,
while
levels
interleukin
(IL)-6,
IL-1β,
tumor
necrosis
(TNF)-α,
myeloperoxidase
(MPO)
increased.
However,
exhibited
effect
function
relevant
tests.
In
addition,
we
found
contents
MDA,
LPO
MCAO/R
rats
GSH
inhibit
ferroptosis.
Furthermore,
Western
blot
treatment
edaravone,
Nrf2,
GPX4,
up-regulated,
location
inflammation-related
indicators
IL-6,
TNF-α,
MPO
lower
than
group.
Our
demonstrated
inhibits
ferroptosis
attenuate
CIRI,
probably
through
activation
Nrf2/FPN
pathway.
Scientific Reports,
Journal Year:
2020,
Volume and Issue:
10(1)
Published: June 10, 2020
Abstract
Optical
intrinsic
signal
imaging
(OISi)
method
is
an
optical
technique
to
evaluate
the
functional
connectivity
(FC)
of
cortex
in
animals.
Already,
using
OISi,
FC
has
been
measured
time
or
frequency
domain
separately,
and
at
frequencies
below
0.08
Hz,
which
not
range
hemodynamic
oscillations
are
able
track
fast
cortical
events,
including
neurogenic,
myogenic,
cardiac
respiratory
activities.
In
current
work,
we
calculated
wavelet
coherence
(WC)
transform
OISi
series
cerebral
response
changes
stroke
rats.
Utilizing
WC,
up
4.5
could
monitor
dependency
simultaneously.
The
results
showed
that
WC
brain
diminished
significantly
ischemic
motor
somatosensory
cortices.
According
statistical
results,
amplitude,
responsive
area
size,
correlation,
cortices
for
hemisphere
were
found
be
lower
compared
healthy
hemisphere.
obtained
confirm
OISi-based
analysis
efficient
diagnose
relative
severity
infarction
size
infarcted
region
after
stroke.
Stem Cells Translational Medicine,
Journal Year:
2020,
Volume and Issue:
10(3), P. 357 - 373
Published: Nov. 4, 2020
Lithium
is
neuroprotective
in
preclinical
stroke
models.
In
addition
to
that,
poststroke
neuroregeneration
stimulated
upon
transplantation
of
mesenchymal
stem
cells
(MSCs).
Preconditioning
MSCs
with
lithium
further
enhances
the
neuroregenerative
potential
MSCs,
which
act
by
secreting
extracellular
vesicles
(EVs).
The
present
work
analyzed
whether
MSC
preconditioning
modifies
EV
secretion
patterns,
enhancing
therapeutic
such
derived
EVs
(Li-EVs)
comparison
enriched
from
native
MSCs.
Indeed,
Li-EVs
significantly
enhanced
resistance
cultured
astrocytes,
microglia,
and
neurons
against
hypoxic
injury
when
compared
controls
EV-treated
cells.
Using
a
mouse
model,
intravenous
delivery
increased
neurological
recovery
for
as
long
3
months
mice,
albeit
latter
also
showed
better
behavioral
test
performance
controls.
changed
patterns
EVs,
modifying
contents
various
miRNAs
within
these
vesicles.
As
such,
displayed
levels
miR-1906,
has
been
shown
be
new
regulator
toll-like
receptor
4
(TLR4)
signaling.
reduced
posthypoxic
postischemic
TLR4
abundance,
resulting
an
inhibition
nuclear
factor
kappa-light-chain-enhancer
activated
B
(NF-κB)
signaling
pathway,
decreased
proteasomal
activity,
declined
both
inducible
NO
synthase
cyclooxygenase-2
expression,
all
culminated
cerebral
inflammation.
Conclusively,
study
demonstrates,
first
time,
interfering
novel
pathway
that
yields
acute
neuroprotection
recovery.
Stroke,
Journal Year:
2018,
Volume and Issue:
49(5), P. 1257 - 1266
Published: April 10, 2018
Cognitive
impairment
is
a
common
outcome
for
stroke
survivors.
Growth
hormone
(GH)
could
represent
potential
therapeutic
option
as
this
peptide
has
been
shown
to
improve
cognition
in
various
clinical
conditions.
In
study,
we
evaluated
the
effects
of
peripheral
administration
GH
at
48
hours
poststroke
28
days
on
cognitive
function
and
underlying
mechanisms.Experimental
was
induced
by
photothrombotic
occlusion
young
adult
mice.
We
assessed
associative
memory
domain
using
mouse
touchscreen
platform
paired-associate
learning
task.
also
neural
tissue
loss,
neurotrophic
factors,
markers
neuroplasticity
cerebrovascular
remodeling
biochemical
histology
analyses.Our
results
show
that
GH-treated
stroked
mice
made
significant
improvement
task
relative
non-GH-treated
end
study.
Furthermore,
observed
reduction
loss
identified
treatment
resulted
significantly
higher
levels
factors
(IGF-1
[insulin-like
growth
factor-1]
VEGF
[vascular
endothelial
factor])
both
circulatory
peri-infarct
regions.
not
only
promoted
protein
density
presynaptic
marker
(SYN-1
[synapsin-1])
myelination
(MBP
[myelin
basic
protein])
but
increased
area
coverage
2
major
vasculature
(CD31
collagen-IV),
within
region.These
findings
provide
compelling
preclinical
evidence
usage
tool
recovery
phase
patients
after
stroke.